Home | Publications | Rheumatoid Arthritisprmainsights

PRMA Insights: The Roadmap to Pricing and Reimbursement Success

Each publication delivers The scope of each publication Who should read PRMA Insights Reasons to buy
NSCLC Psoriasis Metastatic Breast Cancer Type 2 Diabetes Renal Cell Carcinoma COPD Oncology products with companion diagnostics Rheumatoid arthritis Non-Hodgkin's lymphoma flyer
prmaconsulting prmavirtual

PRMA Insights: the Roadmap to Pricing and Reimbursement Success in Rheumatoid Arthritis


Use this 500+ page strategic resource to:

  • Design a roadmap for your therapeutic–diagnostic combination to achieve successful global market access
  • Ensure your strategic plan reflects current and future market access realities
  • Understand the pricing and reimbursement implications for therapeutic–diagnostic combinations in the US, UK, France, Germany, Spain, Italy, and Australia
  • Develop and refine pricing and reimbursement strategies to take account of the latest developments in the reimbursement environment
  • Build forecast models that reflect market access realities
  • Inform candidate selection and R&D portfolio prioritization
  • Facilitate negotiations with partners developing diagnostics or therapeutics
  • Assess in-licensing opportunities and identify market access levers to negotiate favorable deal terms


To find out more about this publication and how it can help you optimize your product development download the brochure:

Download rheumatoid arthritis brochure

prmainsights
Tel: +44 (0) 1252 624429 Email: info@prmainsights.comTerms & ConditionsPrivacy Policy